Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/BAYER-AG-436063/news/U-S-FDA-genehmigt-zusatzliche-Indikation-fur-NUBEQA-Darolutamid-in-Kombination-mit-Docetaxel-zu-41223695/?utm_source=whatsapp&utm_medium=social&utm_campaign=share